The U.S. Department of Agriculture (USDA) has granted conditional use to the world’s first-ever vaccine for honeybees that could prevent colonies from getting infected with American foulbrood, a type of bacterial disease that affects the bee’s larvae.
Dalan Animal Health, the U.S.-based biotech company that developed the vaccine, announced the approval in a Jan. 4 statement.